Paradigm Biopharmaceuticals Ltd
ASX:PAR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Paradigm Biopharmaceuticals Ltd
ASX:PAR
|
AU |
|
E
|
EssilorLuxottica SA
MIL:EL
|
FR |
|
V
|
Valero Energy Corp
SWB:V1L
|
US |
|
Kko International SA
PAR:ALKKO
|
BE |
|
Amdocs Ltd
NASDAQ:DOX
|
US |
|
Siemens Healthineers AG
F:SHL
|
DE |
|
T
|
Tristate Holdings Ltd
XBER:TVX
|
HK |
|
I
|
International Container Terminal Services Inc
OTC:ICTEF
|
PH |
|
GlaxoSmithKline PLC
LSE:GSK
|
UK |
|
Jet2 PLC
LSE:JET2
|
UK |
|
S
|
Satin Creditcare Network Ltd
BSE:539404
|
IN |
|
G
|
Gamuda Bhd
KLSE:GAMUDA
|
MY |
|
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
MY |
|
Qudian Inc
NYSE:QD
|
CN |
Bankruptcy Probability
Paradigm Biopharmaceuticals Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Paradigm Biopharmaceuticals Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Paradigm Biopharmaceuticals Ltd
ASX:PAR
|
62.1m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
401.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Paradigm Biopharmaceuticals Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Paradigm Biopharmaceuticals Ltd has total debt of 9.2m AUD. This includes both short-term (8.8m AUD) and long-term (436.8k AUD) debt.
You can find a full breakdown on its Balance Sheet.
